Remove 2023 Remove Blog Remove COVID-19 Remove Prescription Drug Pricing
article thumbnail

CMS Releases Guidance on Implementation of Rebate Programs for Certain Medicare Part B and Part D Drugs

Healthcare Law Blog

The Rebate Programs are administered as part of the prescription drug affordability provisions of the Inflation Reduction Act (the “IRA”), which is aimed at “lower[ing] out-of-pocket drug costs for people with Medicare and improv[ing] the sustainability of the Medicare program for current and future generations.” [1]

article thumbnail

The Health Consumer in 2024 – The Health Populi TrendCast

Jane Sarashon

At the end of each year since I launched the Health Populi blog, I have put my best forecasting hat on to focus on the next year in health and health care. Economy Inflation, a top-of-mind stress and concern for mainstream Americans in 2023, is easing as we enter 2024. Consumer in the Big/Macro U.S.